Inflammatory disorders: Targeting TRAFs tames inflammation.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 6, p. 423, doi. 10.1038/nrd4029
- By:
- Publication type:
- Article
Works matching IS 14741776 AND DT 2013 AND VI 12 AND IP 6
Results: 29
1
2
Maturing antibody-drug conjugate pipeline hits 30.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 6, p. 483, doi. 10.1038/nrd4034
- By:
- Publication type:
- Article
3
LifeTrain: towards a European framework for continuing professional development in biomedical sciences.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 6, p. 407, doi. 10.1038/nrd4026
- By:
- Publication type:
- Article
4
Targeting long non-coding RNA to therapeutically upregulate gene expression.
- Published in:
- 2013
- By:
- Publication type:
- journal article
5
Integrin inhibitors go with the gut.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 6, p. 411, doi. 10.1038/nrd4037
- By:
- Publication type:
- Article
6
Targeting long non-coding RNA to therapeutically upregulate gene expression.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 6, p. 433, doi. 10.1038/nrd4018
- By:
- Publication type:
- Article
7
Neurodegenerative diseases: simple amyloids to provide protection in MS?
- Published in:
- 2013
- By:
- Publication type:
- journal article
8
Pharmacological approaches to restore mitochondrial function.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 6, p. 465, doi. 10.1038/nrd4023
- By:
- Publication type:
- Article
9
Measurements of ligand bias and functional affinity.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 6, p. 483, doi. 10.1038/nrd3954-c2
- By:
- Publication type:
- Article
10
All-oral HCV therapies near approval.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 6, p. 409, doi. 10.1038/nrd4036
- By:
- Publication type:
- Article
11
G protein-coupled receptors: Pioneering Frizzled family receptor structure solved.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 6, p. 424, doi. 10.1038/nrd4030
- By:
- Publication type:
- Article
12
Trial watch: Opioid receptor blocker shows promise in Phase II depression trial.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 6, p. 415, doi. 10.1038/nrd4028
- By:
- Publication type:
- Article
13
Quantifying biased agonism: understanding the links between affinity and efficacy.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 6, p. 483, doi. 10.1038/nrd3954-c1
- By:
- Publication type:
- Article
14
What matters most in commercial success: first-in-class or best-in-class?
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 6, p. 419, doi. 10.1038/nrd4035
- By:
- Publication type:
- Article
15
Drug spending down.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 6, p. 413, doi. 10.1038/nrd4046
- Publication type:
- Article
16
Anticancer drugs: A new target for melanoma.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 6, p. 424, doi. 10.1038/nrd4040
- By:
- Publication type:
- Article
17
Anticancer drugs: Blocking RAS effects.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 6, p. 422, doi. 10.1038/nrd4033
- By:
- Publication type:
- Article
18
Nanotechnology: Going for gold alone.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 6, p. 424, doi. 10.1038/nrd4043
- By:
- Publication type:
- Article
19
Clinical trial transparency plans hit a snag.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 6, p. 413, doi. 10.1038/nrd4047
- Publication type:
- Article
20
Animal models: Capturing AD features in a novel rat model.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 6, p. 424, doi. 10.1038/nrd4041
- By:
- Publication type:
- Article
21
Patent watch.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 6, p. 416, doi. 10.1038/nrd4049
- By:
- Publication type:
- Article
22
Menelas Pangalos.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 6, p. 418, doi. 10.1038/nrd4044
- By:
- Publication type:
- Article
23
Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 6, p. 447, doi. 10.1038/nrd4010
- By:
- Publication type:
- Article
24
Regulatory watch: Enhanced chance of success for protein replacement therapies.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 6, p. 414, doi. 10.1038/nrd4027
- By:
- Publication type:
- Article
25
In this issue.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 6, p. 405, doi. 10.1038/nrd4039
- Publication type:
- Article
26
The most transformative drugs of the past 25 years: a survey of physicians.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 6, p. 425, doi. 10.1038/nrd3977
- By:
- Publication type:
- Article
27
Analgesia: A new player in neuropathic pain pathogenesis.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 6, p. 422, doi. 10.1038/nrd4031
- By:
- Publication type:
- Article
28
Biotech 'not completely out of the woods'.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 6, p. 413, doi. 10.1038/nrd4048
- Publication type:
- Article
29
Malaria: In a class of their own.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 6, p. 424, doi. 10.1038/nrd4042
- By:
- Publication type:
- Article